Dr. Stephen T. Sinatra – Trademark Portfolio
Entity Type: 01
Dr. Stephen T. Sinatra holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DR. SINATRA and DR. STEPHEN SINATRA. The owner is based in Manchester, CT.
257 East Center Street
Manchester, CT 06040
Showing of trademarks Trademarks
Trademark Classifications
Dr. Stephen T. Sinatra's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Dr. Stephen T. Sinatra have?
Dr. Stephen T. Sinatra has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.
What trademark classes does Dr. Stephen T. Sinatra file in?
Dr. Stephen T. Sinatra files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Dr. Stephen T. Sinatra's most well-known trademarks?
Dr. Stephen T. Sinatra's registered trademark portfolio includes well-known marks such as DR. SINATRA and DR. STEPHEN SINATRA. These are among 3 currently registered trademarks in the portfolio.
What is Dr. Stephen T. Sinatra's trademark registration success rate?
Dr. Stephen T. Sinatra has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.